Drug Trial Radar · NCT06362746
Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism
Last checked: Nov 20, 2026Latest source record: Dec 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
486
Planned (sponsor's estimate)
Start
May 23, 2024
Primary completion
Jun 1, 2028
Study completion Dec 1, 2028
Sponsor
- Lead sponsor
- Supergene, LLCIndustry
- Sponsor type
- Industry
- First posted
- Apr 12, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Objective: to evaluate the efficacy and safety of the non-immunogenic recombinant staphylokinase with its single bolus administration in comparison with placebo in normotensive patients with intermediate high-risk pulmonary embolism (PE)
Conditions
- Pulmonary Embolism
Interventions
Non-immunogenic recombinant staphylokinaseDrug
15 mg of drug reconstituted in 15 ml of 0.9% solution of NaCl given as single i.v. bolus over 10-15 seconds
PlaceboDrug
15 mg of placebo reconstituted in 15 ml of 0.9% solution of NaCl given as single i.v. bolus over 10-15 seconds
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite of death from any cause or hemodynamic collapse or recurrent PETime frame: within 30 days
Locations
24 sites in 1 country. Site status is shown where the registry gives one.
Belgorod Regional Clinical Hospital of St. Joseph
Belgorod, Russia · Recruiting
Kuzbass Cardiology center
Kemerovo, Russia · Recruiting
Center of Neurology and Cardiology
Kirov, Russia · Recruiting
Regional Clinical Hospital №2
Krasnodar, Russia · Recruiting
Lipetsk City Hospital No. 4 "Lipetsk-Med"
Lipetsk, Russia · Recruiting
F.I. Inozemtsev City Clinical Hospital
Moscow, Russia · Recruiting
Moscow Multidisciplinary Clinical Center "Kommunarka"
Moscow, Russia · Recruiting
S.S. Yudin City Clinical Hospital
Moscow, Russia · Recruiting
V.M. Buyanov City Clinical Hospital
Moscow, Russia · Recruiting
S.P. Botkin City Clinical Hospital
Moscow, Russia · Recruiting
N.A. Semashko Nizhny Novgorod Regional Clinical Hospital
Nizhny Novgorod, Russia · Recruiting
N.N. Burdenko Penza Regional Clinical hospital
Penza, Russia · Withdrawn
G.A. Zakharyin Clinical hospital №6
Penza, Russia · Recruiting
City Clinical Hospital №4
Perm, Russia · Withdrawn
City Hospital No. 26
Saint Petersburg, Russia · Recruiting
City Hospital No. 15
Saint Petersburg, Russia · Recruiting
V.P. Polyakov Samara Regional Clinical Cardiology Dispensary
Samara, Russia · Recruiting
Tomsk regional cilinical hospital
Tomsk, Russia · Recruiting
Tver Regional Clinical Hospital
Tver', Russia · Recruiting
Ufa Emergency City Hospital
Ufa, Russia · Recruiting
City Clinical Hospital of Emergency medicine №25
Volgograd, Russia · Recruiting
RZD Medicine hospital
Barnaul, Altayskiy Kray, Russia · Recruiting
V.F. Dolgopolov Vyselki Central District Hospital
Vyselki, Krasnodarskiy Kray, Russia · Recruiting
Asinovskaya District Hospital
Asino, Tomsk Oblast, Russia · Completed
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.